These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3736 related articles for article (PubMed ID: 7336169)

  • 21. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
    Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro.
    Kawashima I; Tada N; Fujimori T; Tai T
    J Biochem; 1990 Jul; 108(1):109-15. PubMed ID: 2121721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
    Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE
    Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1.
    Chattopadhyay P; Kaveri SV; Byars N; Starkey J; Ferrone S; Raychaudhuri S
    Cancer Res; 1991 Nov; 51(22):6045-51. PubMed ID: 1933867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis.
    Cheresh DA; Honsik CJ; Staffileno LK; Jung G; Reisfeld RA
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5155-9. PubMed ID: 3860849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
    Christiaansen JE; Sears DW
    Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma.
    Munn DH; Cheung NK
    Cancer Res; 1987 Dec; 47(24 Pt 1):6600-5. PubMed ID: 3499978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma.
    Nisticò P; Mortarini R; De Monte LB; Mazzocchi A; Mariani M; Malavasi F; Parmiani G; Natali PG; Anichini A
    J Clin Invest; 1992 Sep; 90(3):1093-9. PubMed ID: 1387883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.
    Wilson BS; Imai K; Natali PG; Ferrone S
    Int J Cancer; 1981 Sep; 28(3):293-300. PubMed ID: 7033148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
    Sung MW; Johnson JT; Van Dongen G; Whiteside TL
    Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
    Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor.
    Reinhold U; Liu L; Lüdtke-Handjery HC; Heuser C; Hombach A; Wang X; Tilgen W; Ferrone S; Abken H
    J Invest Dermatol; 1999 May; 112(5):744-50. PubMed ID: 10233766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
    Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
    Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biosynthesis and intracellular processing of four human melanoma associated antigens.
    Kantor RR; Albino AP; Ng AK; Ferrone S
    Cancer Res; 1986 Oct; 46(10):5223-8. PubMed ID: 2428476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects.
    Luo W; Ko E; Hsu JC; Wang X; Ferrone S
    J Immunol; 2006 May; 176(10):6046-54. PubMed ID: 16670313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
    Giacomini P; Natali P; Ferrone S
    J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of human melanoma-associated antigens defined by murine monoclonal antibodies in allogeneic and xenogeneic hosts.
    Hamby CV; Liao SK; Kanamaru T; Ferrone S
    Cancer Res; 1987 Oct; 47(20):5284-9. PubMed ID: 3115563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idiotypic cascade in the human high molecular weight melanoma-associated antigen system: fine specificity and idiotypic profile of anti-anti-idiotypic monoclonal antibodies.
    Yang H; Chen ZJ; Kageshita T; Yamada M; Ferrone S
    Eur J Immunol; 1993 Jul; 23(7):1671-7. PubMed ID: 7686858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro.
    Harel W; Shau H; Hadley CG; Morgan AC; Reisfeld RA; Cheresh DA; Mitchell MS
    Cancer Res; 1990 Oct; 50(19):6311-5. PubMed ID: 2400994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Woodhouse CS; Morgan AC
    Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 187.